ALB and neoplasm: Preserved ALB stability during early treatment may reflect intact systemic immune competence and reduced tumor-induced catabolism—two important determinants of effective anti-tumor immunity that extend beyond the static nutritional assessment provided by baseline albumin measurements alone.